AMN
Indian Council of Medical Research, ICMR has said that consuming the anti malarial drug- Hydroxychloroquine reduces the chances of getting infected with corona virus. ICMR has issued the revised advisory on the use of Hydroxychloroquine
The Joint Monitoring Group including experts from top research bodies and hospitals reviewed the prophylactic use of Hydroxychloroquine in the context of expanding it to healthcare and other front line workers deployed in non-Covid and Covid areas, respectively.
The National Task force constituted by ICMR for Covid-19, also reviewed the use of Hydroxychloroquine for prophylaxis of corona virus infection for high risk population based on the emerging evidence on its safety and efficacy. Investigation done by three central government hospitals in New Delhi indicates that those healthcare workers who have taken Hydroxychloroquine were less likely to develop corona infection compared to those who were not taking it.
A study of 334 healthcare workers at AIIMS, New Delhi also showed that those taking Hydroxychloroquine had lower incidence of covid-19 infection. Based on the available evidence, it has been suggested that Hydroxychloroquine is relatively safe and has some beneficial effect. ICMR recommended that the drug has to be given under strict medical supervision with an informed consent. It has also been advised to consult with a physician for any adverse effect of this drug.